Published by Josh White on 3rd January 2023
(Sharecast News) - Predictive genetics specialist GENinCode announced California state licensing approval and CLIA certification of its Irvine laboratory on Tuesday, enabling it to provide its products for the risk assessment of cardiovascular disease (CVD) to patients across 49 states in the US.